Basel Medical Group Ltd SEC filings BMGL
Basel Medical Group Ltd has 84 filings in SEC EDGAR's recent list, going back to Feb 9, 2024. Its latest annual report, Form 20-F, was filed on Oct 30, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Oct 29, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Oct 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 29, 2026 | Oct 29, 2026 |
| 6-K | Current report (foreign issuer) | Oct 13, 2026 | Oct 13, 2026 |
| 6-K | Current report (foreign issuer) | Oct 9, 2026 | Oct 9, 2026 |
| 424B4 | Prospectus | Oct 8, 2026 | — |
| EFFECT | Filing | Sep 29, 2026 | — |
| F-1/A | Filing | Sep 23, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Sep 17, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 2, 2026 | Sep 2, 2026 |
| 6-K | Current report (foreign issuer) | Aug 10, 2026 | Aug 10, 2026 |
| DRS | Filing | Jul 31, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 10, 2026 | Jul 10, 2026 |
| 6-K | Current report (foreign issuer) | Jun 26, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Jun 10, 2026 | Jun 10, 2026 |
| 6-K | Current report (foreign issuer) | Jun 5, 2026 | Jun 5, 2026 |
| 6-K | Current report (foreign issuer) | Mar 30, 2026 | Mar 30, 2026 |
| 6-K | Current report (foreign issuer) | Mar 24, 2026 | Mar 24, 2026 |
| 20-F/A | Amended annual report (foreign issuer) | Mar 13, 2026 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jan 23, 2026 | Jan 23, 2026 |
| 6-K | Current report (foreign issuer) | Jan 21, 2026 | Jan 21, 2026 |
| 6-K | Current report (foreign issuer) | Dec 1, 2025 | Nov 30, 2025 |
| 20-F | Annual report (foreign issuer) | Nov 18, 2025 | Jun 30, 2025 |
| NT 20-F | Filing | Oct 27, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Aug 21, 2025 | Aug 21, 2025 |
| 6-K | Current report (foreign issuer) | Aug 13, 2025 | Aug 13, 2025 |
| 6-K | Current report (foreign issuer) | Jul 18, 2025 | Jul 18, 2025 |
| 6-K | Current report (foreign issuer) | Jul 2, 2025 | Jul 1, 2025 |
| 6-K | Current report (foreign issuer) | Jun 26, 2025 | Jun 26, 2025 |
| 6-K | Current report (foreign issuer) | Jun 18, 2025 | Jun 18, 2025 |
| 6-K | Current report (foreign issuer) | Jun 3, 2025 | May 31, 2025 |
| 6-K | Current report (foreign issuer) | May 22, 2025 | May 22, 2025 |
| 6-K | Current report (foreign issuer) | May 16, 2025 | May 16, 2025 |
| 6-K | Current report (foreign issuer) | Apr 30, 2025 | Apr 30, 2025 |
| 6-K | Current report (foreign issuer) | Apr 21, 2025 | Apr 21, 2025 |
| 6-K | Current report (foreign issuer) | Apr 11, 2025 | Apr 11, 2025 |
| 6-K | Current report (foreign issuer) | Apr 4, 2025 | Apr 4, 2025 |
| 6-K | Current report (foreign issuer) | Mar 25, 2025 | Mar 25, 2025 |
| 6-K | Current report (foreign issuer) | Mar 19, 2025 | Mar 19, 2025 |
| 6-K | Current report (foreign issuer) | Mar 6, 2025 | Mar 6, 2025 |
| 6-K | Current report (foreign issuer) | Mar 3, 2025 | Mar 3, 2025 |
| 6-K | Current report (foreign issuer) | Feb 28, 2025 | Feb 28, 2025 |
| 424B4 | Prospectus | Feb 25, 2025 | — |
| 424B4 | Prospectus | Feb 25, 2025 | — |
| CERT | Filing | Feb 21, 2025 | — |
| EFFECT | Filing | Feb 18, 2025 | — |
| 8-A12B | Filing | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| F-1/A | Filing | Feb 13, 2025 | — |
| FWP | Free writing prospectus | Dec 13, 2024 | — |
| CORRESP | Letter to the SEC | Dec 3, 2024 | — |
| F-1/A | Filing | Dec 3, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2024 | — |
| CORRESP | Letter to the SEC | Nov 14, 2024 | — |
| F-1/A | Filing | Nov 14, 2024 | — |
| CORRESP | Letter to the SEC | Nov 4, 2024 | — |
| F-1/A | Filing | Nov 4, 2024 | — |
| CORRESP | Letter to the SEC | Sep 13, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Sep 13, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2024 | — |
| DRS/A | Filing | Aug 29, 2024 | — |
| DRSLTR | Filing | Aug 28, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2024 | — |
| DRSLTR | Filing | Jun 21, 2024 | — |
| DRS/A | Filing | Jun 21, 2024 | — |
| UPLOAD | Letter from the SEC | May 29, 2024 | — |
| DRSLTR | Filing | May 8, 2024 | — |
| DRS/A | Filing | May 8, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2024 | — |
| DRSLTR | Filing | Mar 18, 2024 | — |
| DRS/A | Filing | Mar 18, 2024 | — |
| DRSLTR | Filing | Feb 9, 2024 | — |
| DRS | Filing | Feb 9, 2024 | — |
Showing 73 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- BMGL (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Virgin Islands, British
- Headquarters
- Singapore, Singapore
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2004489
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- Starling Oncology, Inc. STLN
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.